CB Health Ventures
Description
CB Health Ventures is a Boston-based venture capital firm with a dedicated focus on the healthcare sector. Established in 1997, the firm manages a total of $150 million across its private equity funds, targeting investment opportunities primarily within healthcare services, medical devices, and healthcare information technology. Their long-standing presence in the market underscores a consistent commitment to fostering innovation and growth in critical areas of the healthcare industry.
The firm's investment strategy centers on early and growth-stage healthcare companies. CB Health Ventures typically deploys initial investments ranging from $3 million to $10 million, with additional capital reserved for subsequent follow-on rounds to support portfolio companies as they scale. This approach allows them to provide substantial capital to promising ventures while maintaining the flexibility to participate in future financing needs.
CB Health Ventures actively seeks companies that demonstrate strong fundamentals, including proven management teams, proprietary technologies or services, and access to significant market opportunities. Their expertise spans various sub-sectors within healthcare, enabling them to identify and nurture businesses that are poised to make a substantial impact. With a portfolio that includes investments in over 30 companies since its inception, the firm has a track record of backing innovative solutions across the healthcare value chain.
Investor Profile
CB Health Ventures has backed more than 46 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 2% of its total and boasts 21 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Private Equity, Series B, Series C rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Health Care, Biotechnology, Medical.
- Typical check size: $3M – $10M.
Stage Focus
- Private Equity (30%)
- Series B (22%)
- Series C (15%)
- Series A (15%)
- Series E (7%)
- Series D (4%)
- Series Unknown (4%)
- Seed (2%)
Country Focus
- United States (98%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Health Diagnostics
- Genetics
- Software
- Medical Device
- Wellness
- Analytics
- Pharmaceutical
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
